Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ETRAElectra Therapeutics, Inc.

Nasdaq · CIK 0002088082
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts114

Identity from submissions API

NameElectra Therapeutics, Inc.
CIK0002088082
TickersETRA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN832193635
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(888) 743-2290
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
230 EAST GRAND AVENUE, SUITE S-100
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
230 EAST GRAND AVENUE, SUITE S-100
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

41 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005295 005-95943 261559149 34 10654
2026-11-12 10-Q 10-Q 0001193125-26-458476 001-43477 261547292 34 11925931 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458464 001-43477 261547240 34 368384 1 1
2026-11-10 4 xslF345X06/ownership.xml 0000947871-26-001011 15465
2026-11-10 4 xslF345X06/ownership.xml 0000947871-26-001010 19373
2026-11-05 4 xslF345X06/ownership.xml 0000947871-26-000986 22215
2026-11-05 4 xslF345X06/ownership.xml 0000947871-26-000985 26123
2026-10-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-120294 005-95943 261503155 34 58469
2026-09-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-111478 005-95943 261418857 34 18130
2026-09-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-405752 005-95943 261418850 34 134891
2026-09-25 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000898 005-95943 261411207 34 35322
2026-09-23 4 xslF345X06/ownership.xml 0000947871-26-000881 25529
2026-09-23 4 xslF345X06/ownership.xml 0000947871-26-000880 29437
2026-09-21 3 OWNERSHIP DOCUMENT 0001104659-26-109399 11860
2026-09-21 4 xslF345X06/form4-09212026_100905.xml 0002153365-26-000004 7283
2026-09-21 4 xslF345X06/form4-09212026_100957.xml 0001817449-26-000009 7292
2026-09-21 4 xslF345X06/form4-09212026_100928.xml 0002153366-26-000006 7656
2026-09-21 4 xslF345X06/form4-09212026_100932.xml 0002153364-26-000004 7675
2026-09-21 S-8 S-8 0001193125-26-396741 333-299059 261394433 33 247606 1 1
2026-09-21 8-K 8-K 5.03,8.01,9.01 0001193125-26-396646 001-43477 261393832 34 186872 1 1
2026-09-18 424B4 424B4 0001193125-26-395670 333-298617 261391561 33 6967800
2026-09-18 3 xslF345X06/ownership.xml 0000947871-26-000874 14519
2026-09-18 3 xslF345X06/form3-09182026_080937.xml 0002153761-26-000002 11180
2026-09-18 3 xslF345X06/form3-09182026_080936.xml 0001397266-26-000004 12541
2026-09-18 3 xslF345X06/form3-09182026_080923.xml 0002153198-26-000002 16904
2026-09-18 3 xslF345X06/form3-09182026_080916.xml 0002153366-26-000004 16745
2026-09-18 3 xslF345X06/form3-09182026_080910.xml 0002153366-26-000003 11174
2026-09-18 3 xslF345X06/form3-09182026_080956.xml 0002153365-26-000002 19326
2026-09-18 3 xslF345X06/form3-09182026_080950.xml 0001282930-26-000012 16396
2026-09-18 3 xslF345X06/form3-09182026_080900.xml 0002153768-26-000002 11221
2026-09-18 3 xslF345X06/form3-09182026_080919.xml 0001817449-26-000007 13949
2026-09-18 3 xslF345X06/form3-09182026_080911.xml 0002153364-26-000002 19745
2026-09-18 CERT ETRA_8A_Cert_2088082.pdf 0001354457-26-000887 001-43477 261388807 34 549057
2026-09-18 8-A12B 8-A12B 0001193125-26-394994 001-43477 261388402 34 14255
2026-09-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002994 333-298617 261388329 33 1787
2026-09-17 S-1MEF S-1MEF 0001193125-26-394715 333-298997 261388085 33 191053 1 1
2026-09-14 S-1/A S-1/A 0001193125-26-389755 333-298617 261375721 33 8948257 1 1
2026-08-28 S-1 S-1 0001193125-26-374259 333-298617 261339631 33 8684073 1 1
2026-08-10 DRS/A filename1.htm 0001193125-26-342694 377-09513 261259575 33 6263746
2026-06-26 DRS filename1.htm 0001193125-26-285726 377-09513 261130561 33 5982009
2025-10-30 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000372 021-562489 251431398 33 10300

Latest XBRL company facts

One latest value per concept from companyfacts (114 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 62.87M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
ffd NetFeeAmt NetFeeAmt USD 21,484.04 2026-09-18 S-8 2026-09-21 0001193125-26-396741
ffd TtlFeeAmt TtlFeeAmt USD 21,484.04 2026-09-18 S-8 2026-09-21 0001193125-26-396741
ffd TtlOfferingAmt TtlOfferingAmt USD 155.57M 2026-09-18 S-8 2026-09-21 0001193125-26-396741
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-18 S-8 2026-09-21 0001193125-26-396741
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-17 S-1MEF 2026-09-17 0001193125-26-394715
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 8.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 858,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 638.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.49M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap Assets Assets USD 410.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AssetsCurrent Assets, Current USD 406.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 152.60M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 73.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 73.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 79.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 79.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 152.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 256.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 402.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 256.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 223.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 900.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 62.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 62.87M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -72.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 311.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 40.00M 2025-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 39.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 20.00M 2025-03-07 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2025-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 41.40M 2025-10-15 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 900,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions Security 25 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 100,000 2025-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 5.50M 2026-09-21 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 183,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -35.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -35.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 44.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -83,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 2.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 2.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -377,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -5.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap InterestExpenseDebt Interest Expense, Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap InterestIncomeOther Interest Income, Other USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap Liabilities Liabilities USD 17.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 410.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap LiabilitiesCurrent Liabilities, Current USD 16.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap LongTermDebt Long-term Debt USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 146.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 372.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -91.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -57.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -72.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -82.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingExpenses Operating Expenses USD 75.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -75.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 771,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 939,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 536,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 26,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 804,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 1.62M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 149.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-21 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-21 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PrepaidInsurance Prepaid Insurance USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 325.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ProceedsFromIssuanceOfCommercialPaper Proceeds from Issuance of Commercial Paper USD 40.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 49.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 57.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 509,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 518,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 58.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -245.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 2.33M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.11 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 392.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 311.17M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 319.99M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 509,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458476

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →